www.fdanews.com/articles/114552-fda-extends-review-time-for-gout-drug
FDA Extends Review Time for Gout Drug
February 13, 2009
Shares of Savient Pharmaceuticals plummeted after the company said federal regulators pushed back the target date to review the company’s treatment for gout.
MSNBC
MSNBC